Blepharophimosis–Intellectual Disability Syndrome, SBBYS Type

Blepharophimosis–Intellectual Disability Syndrome, SBBYS type is a rare genetic condition. Children are born with narrow eyelid openings (blepharophimosis) and droopy eyelids (ptosis). They also have developmental delay and intellectual disability. Many children show a “recognizable face,” such as a small head (microcephaly), a broad or bulbous nose, thin lips, a wide mouth, and often a “mask-like” or low-animation facial look. Some babies have congenital hypothyroidism, feeding difficulties, and weak muscle tone (hypotonia). Other body systems can be affected, such as the skeleton (kneecaps missing or under-developed, finger and toe differences), the heart, the hearing system, the airway, and the genitals (especially in boys). The condition happens because of a change (pathogenic variant) in a single gene called KAT6B, which controls how other genes turn on and off during early development. Most changes occur newly (de novo) in the child, and the condition follows an autosomal dominant pattern (one changed copy is enough). SBBYS is part of a KAT6B-related disorder spectrum that also includes Genitopatellar syndrome; some children have features in between the two. PubMed+4NCBI+4MedlinePlus+4

SBBYS is a genetic syndrome caused by changes (variants) in a gene called KAT6B. This gene helps turn other genes on and off during early development by modifying histones (it is a “histone acetyltransferase”). When KAT6B does not work normally, many body systems can develop differently. Children usually have a characteristic facial look (including blepharophimosis—narrow eyelid openings with ptosis), global developmental delay/intellectual disability, low muscle tone, and a mix of features that can include kneecap problems, joint contractures, genital differences, hearing loss, dental anomalies, heart defects, thyroid issues, and sometimes seizures. SBBYS shares a spectrum with a related disorder called genitopatellar syndrome (GPS); both are “KAT6B disorders.” Orpha.net+4NCBI+4MedlinePlus+4

How common and how it behaves. SBBYS is very rare. Signs can vary widely from one child to another, even within the same family. Newer reports support a continuum between GPS and SBBYS (some children show mixed features). Care is lifelong, typically coordinated by genetics, pediatrics, and organ-specific specialists. GIM Journal+1

---

Other names

• Say-Barber-Biesecker-Young-Simpson syndrome

• SBBYS variant of Ohdo syndrome

• Blepharophimosis–intellectual disability syndrome, SBBYS type

• SBBYSS (abbreviation sometimes used in medical sources) NCBI+2Orpha.net+2

---

Types

Doctors think of SBBYS within the KAT6B-related disorders. There are two main ends of the spectrum:

1. SBBYS (this condition): More facial/eyelid findings (blepharophimosis, ptosis), hypothyroidism is common, “masked” facies, skeletal changes, developmental delay/intellectual disability.

2. Genitopatellar syndrome (GPS): More severe knee and genital anomalies, absent or small kneecaps, flexion contractures; there is clinical overlap with SBBYS.

Some children show overlap features between SBBYS and GPS. NCBI+2PMC+2

---

Causes

In this section, “cause” means a direct or contributing biological reason for the syndrome’s features. The primary cause is a change in the KAT6B gene; the other items explain how that change leads to the body findings.

1. KAT6B gene variant (pathogenic variant). A small DNA change disrupts the KAT6B protein, which is central to normal development. MedlinePlus

2. De novo origin. In most families the change is new in the child and not found in either parent; this is why there is often no family history. PubMed

3. Autosomal dominant mechanism. One altered KAT6B copy is sufficient to cause disease features. Frontiers

4. Protein truncation. Many variants cause a shortened KAT6B protein that cannot work normally. PubMed

5. Abnormal histone acetylation. KAT6B is a histone acetyltransferase; when it is not working, gene expression programs in early embryos are disturbed. MedlinePlus

6. Transcriptional dysregulation. Faulty chromatin remodeling changes when and where other development genes switch on. PMC

7. Abnormal eyelid development. Mis-timed gene programs affect eyelid fissure length and levator muscle function → blepharophimosis/ptosis. Orpha.net

8. Neurodevelopmental pathway disruption. Brain growth and wiring programs are altered, contributing to developmental delay and intellectual disability. NCBI

9. Skeletal patterning defects. The blueprint for kneecaps, digits, ribs, and spine can be disturbed, leading to hypoplastic/absent patellae and hand/foot anomalies. NCBI

10. Endocrine pathway changes. Thyroid development/regulation may be affected, leading to congenital hypothyroidism in many children with SBBYS. Orpha.net+1

11. Craniofacial morphogenesis errors. Midface, palate, and jaw development may be altered → facial traits, occasional cleft palate, feeding challenges. NCBI

12. Neuromuscular tone changes. Early brain and muscle development differences lead to hypotonia (low tone). PubMed

13. Airway/laryngeal anomalies. Voice box and trachea can be affected; some children have airway issues. NCBI

14. Hearing pathway involvement. Middle/inner ear structures and/or neural pathways can be abnormal → hearing loss in some children. NCBI

15. Cardiac development disturbances. Congenital heart defects may occur because cardiac patterning is sensitive to chromatin regulation. NCBI

16. Dental development anomalies. Teeth may form late or be under-developed. Wikipedia

17. Genital development differences. In boys, undescended testes are common; external genitalia differences can occur due to developmental signaling disruption. NCBI

18. Growth regulation effects. Some children have slow growth related to endocrine, feeding, or systemic factors connected to KAT6B dysfunction. NCBI

19. Corpus callosum or structural brain differences. These can contribute to developmental and motor features. NCBI

20. Variable expressivity across the KAT6B spectrum. The same gene can cause a range of features (SBBYS ↔ GPS), which explains child-to-child variation. ScienceDirect

---

Symptoms and signs

1. Narrow eyelid openings (blepharophimosis). The horizontal length of the eyelids is shorter than usual, making the eyes look narrowed. This is present from birth. Orpha.net

2. Droopy upper eyelids (ptosis). The levator muscle that lifts the eyelid is weak or its control is altered, so the eyelids stay low. NCBI

3. Intellectual disability. Learning and problem-solving are delayed. Children may need special education and therapy. NCBI

4. Global developmental delay. Sitting, standing, walking, and talking may happen later. Early intervention helps skills grow over time. PubMed

5. Low muscle tone (hypotonia). Babies feel “floppy,” and motor milestones take longer. Physical therapy supports strength and control. PubMed

6. Congenital hypothyroidism. Low thyroid hormone at birth can add to tiredness, slow growth, and delayed development, but treatment helps. Orpha.net+1

7. Characteristic facial appearance. Features may include microcephaly, a broad/bulbous nose, thin lips, a wide mouth, and a mask-like expression. Orpha.net

8. Feeding difficulties in infancy. Poor latch, weak suck, or reflux can occur and often improve with support and growth. NCBI

9. Hearing loss. Some children have conductive or sensorineural hearing problems; hearing checks are important for language development. NCBI

10. Skeletal differences. Patellae (kneecaps) may be small or missing; fingers and toes can have broad first digits or partial webbing. NCBI

11. Heart defects. Some children are born with structural heart changes, which may need monitoring or repair. NCBI

12. Airway or voice problems. Laryngeal and tracheal differences can cause noisy breathing or a weak cry. ENT evaluation can help. NCBI

13. Genital anomalies (especially in boys). Undescended testes are common; genital surgery and hormone guidance may be needed. NCBI

14. Dental anomalies. Delayed tooth eruption or under-developed teeth may occur; dental care planning is useful. Wikipedia

15. Behavioral and communication challenges. Because of hearing, tone, and cognitive issues, speech and social skills may need extra support. (This follows from the core neurodevelopmental profile.) NCBI

---

Diagnostic tests

Doctors usually start with a careful clinical exam, and then use genetic testing to confirm the diagnosis. The tests below are grouped by category. Not every child needs every test; doctors choose tests based on the child’s signs.

A) Physical examination

1. Comprehensive dysmorphology exam. A geneticist measures head size, facial features, hands/feet, and body proportions to look for the SBBYS pattern and to decide on genetic tests. NCBI

2. Eyelid measurements. The doctor measures palpebral fissure length and eyelid lift (levator function) to document blepharophimosis and ptosis. Orpha.net

3. Growth and thyroid signs check. Height, weight, head growth, skin/hair dryness, and energy level are reviewed because congenital hypothyroidism is common. Orpha.net

4. Muscle tone and joint exam. Hypotonia, joint laxity, or contractures are checked to plan therapies. PubMed

5. Cardiac and respiratory exam. A careful heart and airway check guides the need for echocardiogram or ENT referral. NCBI

B) Manual/bedside tests

6. Vision screening and cover–uncover test. Simple in-office checks for eye alignment and visual tracking; important before and after eyelid surgery decisions. (General ophthalmic practice)

7. Hearing screening (otoacoustic emissions at bedside). A quick, painless newborn/infant check flags possible hearing loss for full audiology testing later. NCBI

8. Neurological bedside exam. Reflexes, tone, and coordination are assessed to gauge developmental needs and decide on imaging. NCBI

9. Feeding/swallow assessment. A speech-language pathologist evaluates suck, swallow, and airway protection when feeding problems are present. NCBI

10. Orthopedic functional checks. Standing, gait, and knee stability are examined because patellae may be small or absent. NCBI

C) Laboratory and pathological tests

11. Thyroid function tests (TSH, free T4). Detects congenital hypothyroidism so treatment can start early. Orpha.net+1

12. Genetic testing – KAT6B sequencing. Reads the KAT6B gene letter by letter to find disease-causing variants; confirms SBBYS. NCBI

13. Deletion/duplication analysis of KAT6B. Looks for missing or extra gene pieces if sequencing is inconclusive. NCBI

14. Chromosomal microarray (CMA). Screens the whole genome for larger copy-number changes that might mimic SBBYS features or coexist. NCBI

15. Exome or genome sequencing. Broad testing that can find KAT6B variants and check for other genes in children with complex signs. ScienceDirect

D) Electrodiagnostic tests

16. Auditory brainstem response (ABR). Measures how the hearing nerve and brainstem respond to sound; useful when behavioral hearing tests are hard. NCBI

17. Electroencephalogram (EEG) if seizures suspected. Looks for abnormal brain electrical activity; some children with KAT6B disorders can have seizures. NCBI

18. Nerve conduction/EMG (selected cases). Used when there are unexplained weakness patterns; helps separate muscle vs nerve causes of hypotonia. (General neuromuscular practice)

E) Imaging and procedures

19. Brain MRI. Checks for structural differences such as corpus callosum anomalies that can be part of the spectrum. NCBI

20. Echocardiogram. Ultrasound of the heart to detect congenital heart defects that may be present. NCBI

21. Skeletal survey or targeted X-rays. Images of knees (patellae), hips, spine, hands, and feet to document skeletal differences. NCBI

22. Renal ultrasound. Kidney screening when clinically indicated, as some anomalies have been reported in the spectrum. NCBI

23. Flexible laryngoscopy or airway endoscopy. ENT specialists check the larynx/trachea if there are airway noises, stridor, or feeding-breathing coordination issues. NCBI

24. Comprehensive ophthalmology exam. Slit-lamp and dilated fundus exam to plan eyelid management and look for associated eye surface issues. Orpha.net

25. Formal audiology (behavioral audiometry, tympanometry). Defines the type and degree of hearing loss to guide hearing aids or other supports. NCBI

Non-pharmacological treatments (therapies & other supports)

1. Early developmental intervention (0–3 years).
   Description. A structured, family-centered program that bundles physical, occupational, and speech therapy plus caregiver training from infancy. Purpose. To promote motor, language, social, and self-help skills during the brain’s most “plastic” window. Mechanism. Repetition and play-based tasks “wire” efficient motor and communication pathways and prevent secondary problems (contractures, feeding refusal, sensory aversion). Early support is recommended for KAT6B disorders because delay is common. NCBI+1

2. Physical therapy (PT) with contracture management.
   Description. Goal-directed gross-motor work (posture, rolling, sitting, standing, walking), daily home stretches, positioning, and splinting/orthoses. Purpose. Improve mobility, balance, and endurance; reduce joint stiffness. Mechanism. Task-specific practice and stretching remodel muscle-tendon length and joint range; orthoses support alignment to prevent deformity, which is relevant in SBBYS due to kneecap anomalies and hip/knee contractures. NCBI

3. Occupational therapy (OT) for hands/self-care.
   Description. Fine-motor training, sensory integration, hand splints, and adaptive tools for dressing/feeding. Purpose. Independence in daily activities. Mechanism. Graded repetition improves motor planning and hand strength; sensory strategies reduce over/under-responsivity. Finger/digit anomalies may need custom splints. NCBI

4. Speech-language therapy (SLT) and Augmentative & Alternative Communication (AAC).
   Description. Early receptive/expressive language therapy; AAC (picture boards, tablets, speech-generating devices) when expressive speech is delayed. Purpose. Give a reliable way to communicate now while speech emerges. Mechanism. Modeling and aided language input build neural language maps; AAC does not block speech—often supports it. NCBI

5. Feeding therapy (SLT/OT) and safe-swallow strategies.
   Description. Oral-motor exercises, texture progression, pacing, and reflux prevention; coordinated with GI/dietitian. Purpose. Reduce aspiration and improve growth. Mechanism. Stepwise exposure and posture changes reduce airway invasion; careful pacing improves swallow-breath coordination. Feeding difficulty is noted in KAT6B disorders. NCBI

6. Vision care & eyelid support prior to surgery.
   Description. Regular pediatric ophthalmology, lubrication, taping guidance, temporary crutches if appropriate. Purpose. Protect the cornea and prevent amblyopia while planning ptosis/blepharoplasty. Mechanism. Moisture and exposure control protect the ocular surface; early optical correction aids visual development. Blepharophimosis is core to SBBYS. Orpha.net

7. Hearing management (audiology) and hearing aids.
   Description. Diagnostic ABR/behavioral audiometry; amplification or bone-anchored options; ear tube care if needed. Purpose. Ensure access to sound for language learning. Mechanism. Amplification restores audibility; managing otitis media prevents conductive loss. Hearing impairment occurs in some patients. National Organization for Rare Disorders

8. Special education & individualized education plans (IEP).
   Description. School-based supports, classroom accommodations, and therapies embedded in learning. Purpose. Optimize academic and functional progress with realistic goals. Mechanism. Multidisciplinary instruction with repetition and visual supports fits cognitive profiles in intellectual disability. MedlinePlus

9. Behavioral therapy (parent training, ABA-informed strategies).
   Description. Structured routines, positive reinforcement, and low-arousal approaches for self-injury, rigidity, or autism-like traits. Purpose. Reduce challenging behaviors and teach replacement skills. Mechanism. Operant learning plus predictable environments lowers anxiety and improves communication. Autism-like features are reported in SBBYS. PMC

10. Orthopedic care & bracing.
    Description. Custom knee/ankle orthoses, serial casting for tight muscles, and posture seating systems. Purpose. Prevent deformity and improve gait in patella hypoplasia and contractures. Mechanism. External support realigns joints; gradual casting lengthens muscle-tendon units. NCBI

11. Dental/craniofacial care.
    Description. Early dental surveillance, enamel protection, fluoride, and orthodontic planning. Purpose. Reduce caries and manage malocclusion/teeth anomalies described in SBBYS. Mechanism. Hygiene plus enamel support lowers decay risk; orthodontics improves function. NCBI

12. Cardiac monitoring & activity clearance.
    Description. Echocardiography at diagnosis and as indicated; tailored exercise guidance. Purpose. Detect congenital heart defects and set safe activity levels. Mechanism. Early detection allows timely intervention and safe participation. NCBI

13. Thyroid and endocrine follow-up.
    Description. Regular TSH/Free T4 (and growth assessment) with pediatric endocrinology. Purpose. Treat congenital hypothyroidism or growth problems quickly. Mechanism. Normalizing thyroid/growth hormones supports brain and body development. National Organization for Rare Disorders

14. Sleep hygiene & positional care.
    Description. Bedtime routines, reflux control, and airway evaluation if snoring or apnea. Purpose. Improve sleep quality which strongly affects learning/behavior. Mechanism. Consistent cues entrain circadian rhythm; reflux/airway treatment reduces arousals. NCBI

15. Respiratory therapy (if weak cough/aspiration).
    Description. Chest physiotherapy and suction training for families when needed. Purpose. Reduce pneumonia risk. Mechanism. Airway clearance lowers secretion burden and infection risk in hypotonia/reflux. NCBI

16. Genetic counseling.
    Description. Education on cause, inheritance (often de novo), and family planning options. Purpose. Informed choices and psychosocial support. Mechanism. Risk assessment and discussion of prenatal/preimplantation options. NCBI

17. Social work & community resources.
    Description. Linkage to disability supports, transport, respite, and financial programs. Purpose. Reduce caregiver burnout; improve access. Mechanism. Practical supports address social determinants of health. NCBI

18. Vision therapy/low-vision aids (select cases).
    Description. Contrast enhancement, magnification, and classroom seating. Purpose. Maximize usable vision pending/after eye surgery. Mechanism. Environmental adaptation improves function despite anatomical eyelid limits. Orpha.net

19. Assistive mobility devices.
    Description. Walkers, standers, wheelchairs as needed. Purpose. Safe movement and participation while building strength. Mechanism. Supported weight-bearing protects joints and promotes fitness. NCBI

20. Caregiver training & emergency plans (seizure/aspiration).
    Description. Step-by-step home plans for seizures, choking, and medication routines. Purpose. Faster, safer responses. Mechanism. Rehearsed actions reduce harm in predictable crises. NCBI

---

Drug treatments

Important: Doses and timing must be individualized by clinicians—below are label-based examples & purposes. Always review contraindications/monitoring in the official label.

1. Levothyroxine (oral; e.g., Synthroid/Levo-T/Ermeza).
   What/why. Replaces missing thyroid hormone in congenital hypothyroidism linked to KAT6B disorders; supports brain and body growth. Class. Thyroid hormone (T4). Typical dosing/timing. Daily, empty stomach; neonatal/pediatric doses are weight-based per label. Mechanism. Restores euthyroid state to normalize metabolism and neurodevelopment. Common cautions. Overtreatment can cause tachycardia/irritability; undertreatment impairs growth. FDA Access Data+2FDA Access Data+2

2. Levothyroxine (IV) for severe hypothyroidism/myxedema in hospital.
   Use. Bridge until oral dosing possible; used in emergencies only. Mechanism/cautions. Rapid replacement with cardiac monitoring due to arrhythmia risk at high doses. FDA Access Data+1

3. Somatropin (growth hormone; Genotropin/Omnitrope/Skytrofa—label examples).
   Use. For documented GH deficiency or approved pediatric growth indications—supports linear growth and body composition when indicated (not universal in SBBYS). Mechanism. Replaces GH to stimulate IGF-1 pathways. Cautions. Monitor for slipped capital femoral epiphysis, glucose effects, intracranial hypertension. FDA Access Data+2FDA Access Data+2

4. Levetiracetam (Keppra / Keppra XR / Spritam).
   Use. Seizure control (adjunct/monotherapy depending on type/age). Mechanism. Modulates synaptic vesicle protein SV2A to stabilize neuronal firing. Cautions. Behavioral changes, somnolence; dose adjust in renal impairment. FDA Access Data+3FDA Access Data+3FDA Access Data+3

5. Valproate / Divalproex (Depakene/Depakote).
   Use. Broad-spectrum antiseizure option where appropriate. Mechanism. Increases GABA, modulates sodium/calcium channels. Cautions. Boxed warnings for hepatotoxicity, teratogenicity, pancreatitis; careful use in females of childbearing potential. FDA Access Data+2FDA Access Data+2

6. Topiramate (Topamax / Trokendi XR).
   Use. Focal/generalized seizures and Lennox–Gastaut. Mechanism. Multiple: AMPA antagonism, sodium channel effects, carbonic anhydrase inhibition. Cautions. Cognitive slowing, kidney stones, weight loss; titrate slowly. FDA Access Data+2FDA Access Data+2

7. Lamotrigine (Lamictal).
   Use. Focal/generalized seizures including Lennox–Gastaut adjunct. Mechanism. Voltage-gated sodium channel modulation. Cautions. Boxed warning for serious rash (SJS/TEN); slow titration essential. FDA Access Data+2FDA Access Data+2

8. Diazepam rectal gel (Diastat).
   Use. Home rescue for seizure clusters while awaiting medical help. Mechanism. Benzodiazepine GABA-A agonist aborts bursts of seizures. Cautions. Sedation/respiratory depression; caregiver training required. FDA Access Data+2FDA Access Data+2

9. Clonazepam (Klonopin).
   Use. Adjunct for certain seizure types, severe myoclonus, or anxiety. Mechanism. Benzodiazepine GABA-A agonist. Cautions. Dependence/withdrawal, sedation. FDA Access Data+2FDA Access Data+2

10. Baclofen (Lyvispah/Fleqsuvy/Ozobax—oral solution forms).
    Use. Spasticity when present (some patients are hypotonic; use only if indicated). Mechanism. GABA-B agonist reduces spinal reflexes. Cautions. Do not stop abruptly; can cause somnolence and weakness. FDA Access Data+2FDA Access Data+2

11. Omeprazole (Prilosec).
    Use. Reflux/erosive esophagitis that worsens feeding or aspiration risk. Mechanism. Proton pump inhibitor blocks acid secretion. Cautions. Use for clear indications; monitor for GI/ID risks with long use. FDA Access Data+2FDA Access Data+2

12. Lansoprazole ODT (Prevacid SoluTab).
    Use. Reflux where ODT is helpful for children with swallowing issues. Mechanism. PPI. Cautions. As above. FDA Access Data+1

13. Polyethylene glycol 3350 (PEG 3350).
    Use. Chronic constipation common in hypotonia/limited mobility. Mechanism. Osmotic laxative draws water into stool. Cautions. Use per label; ensure hydration. FDA Access Data

14. Albuterol (ProAir/Proventil HFA; nebulizer solutions).
    Use. Bronchospasm/reactive airway, including illness-related wheeze. Mechanism. β2-agonist relaxes airway smooth muscle. Cautions. Tremor, tachycardia; avoid overuse. FDA Access Data+2FDA Access Data+2

15. Fluticasone nasal spray (Flonase).
    Use. Allergic rhinitis contributing to mouth-breathing, poor sleep, or otitis media. Mechanism. Topical steroid reduces nasal inflammation. Cautions. Local irritation/epistaxis; rare ocular effects with long use. FDA Access Data+1

16. Ondansetron (Zofran).
    Use. Significant nausea/vomiting that worsens feeding or medication tolerance. Mechanism. 5-HT3 antagonist. Cautions. QT risk at higher doses; follow pediatric guidance. FDA Access Data+2FDA Access Data+2

17. Amoxicillin-clavulanate (Augmentin).
    Use. Bacterial otitis media/sinusitis when indicated (to improve hearing/sleep/feeding). Mechanism. β-lactam + β-lactamase inhibitor. Cautions. Allergy, diarrhea. Use only for proven/suspected bacterial infection. FDA Access Data+1

18. Ofloxacin otic (Floxin Otic).
    Use. Bacterial ear infections when tympanostomy tubes or external otitis complicate hearing. Mechanism. Fluoroquinolone antibiotic drops. Cautions. Avoid if quinolone allergy. FDA Access Data+1

19. Botulinum toxin type A (onabotulinumtoxinA; BOTOX) in selected spastic patterns.
    Use. Focal spasticity impacting hygiene or bracing (specialist use only). Mechanism. Blocks acetylcholine release at neuromuscular junction. Cautions. Risk of spread of toxin effect; used in carefully chosen cases. FDA Access Data

20. Sertraline (Zoloft) for anxiety/OCD-like symptoms when non-drug therapy isn’t enough.
    Use. Improves anxiety/mood regulation that interferes with learning/participation. Mechanism. SSRI increases synaptic serotonin. Cautions. Boxed warning for suicidality in youth; start low, go slow with close follow-up. FDA Access Data+1

---

Dietary molecular supplements

Supplements are not disease cures; use when a deficiency or clear functional need is identified.

1. Omega-3 (DHA/EPA).
   Why/how. May support attention/behavior and reduce inflammation; useful when diet is limited. Mechanism. Incorporates into neuronal membranes and modulates eicosanoids. (Discuss dose per child’s weight; check for fish/bleeding issues.) National Organization for Rare Disorders

2. Vitamin D.
   Why/how. Commonly low in children with limited outdoor exposure or picky eating; supports bone, immunity, and mood. Mechanism. Nuclear receptor signaling for calcium/phosphate and immune modulation; dose guided by serum 25(OH)D. NCBI

3. Calcium.
   Why/how. Needed if intake is low, especially with limited weight-bearing or antiseizure meds that affect bone health. Mechanism. Bone mineralization and neuromuscular function. NCBI

4. Iron (if iron-deficient).
   Why/how. Improves anemia, sleep quality in some restless children, and learning when true deficiency exists. Mechanism. Heme synthesis and neurotransmitter enzymes; dose by ferritin/TSAT. NCBI

5. Vitamin B12/folate (if low).
   Why/how. Corrects macrocytosis and supports myelin and DNA synthesis; confirm deficiency first. Mechanism. Methylation pathways for neurologic function. NCBI

6. Magnesium (constipation/muscle cramps).
   Why/how. Osmotic effect can soften stool; may relax smooth muscle. Mechanism. Cofactor in ATP and neuromuscular transmission. FDA Access Data

7. Probiotics (selected strains) for constipation/antibiotic-associated diarrhea.
   Mechanism. Modulate microbiota and short-chain fatty acids; strain-specific effects. Use when evidence supports the symptom target. NCBI

8. Zinc (if deficient; taste/smell or wound issues).
   Mechanism. Enzymatic cofactor for growth and immune function; dose by labs to avoid copper imbalance. NCBI

9. Coenzyme Q10 (fatigue in mitochondrial-suspect profiles).
   Mechanism. Electron transport chain cofactor supporting cellular energy; evidence mixed—use case-by-case. NCBI

10. Multivitamin with minerals (safety-dosed pediatric formula).
    Mechanism. Backstops selective eating while feeding therapy is underway; avoids megadoses. NCBI

---

Immunity booster / regenerative / stem-cell drugs

There are no FDA-approved stem-cell or “regenerative” drugs for SBBYS. Using unproven stem-cell products can be harmful. What helps immunity most is vaccination, nutrition, sleep, and treating reflux/aspiration. In special situations, clinicians may use:

1. Routine vaccines per schedule (core immune protection; not a “drug” but the strongest, proven immune support). NCBI

2. Influenza/COVID/RSV prevention according to age/eligibility (e.g., nirsevimab for infant RSV per local guidelines). NCBI

3. Antibiotics when truly needed (e.g., Augmentin) to clear bacterial infections that worsen nutrition/hearing/sleep. FDA Access Data

4. Nutritional repletion (iron, vitamin D) when deficient—restores immune function. NCBI

5. Inhaled steroids for chronic rhinitis/asthma when indicated (fluticasone). FDA Access Data

6. IV therapies such as IVIG are not routine in SBBYS and are reserved for proven immune deficiency by specialists.

---

Surgeries (what they are and why done)

1. Ptosis repair / blepharoplasty with canthoplasty.
   Why. To open the palpebral fissure, reduce eyelid droop, protect the cornea, and prevent amblyopia in blepharophimosis. Timing depends on exposure risk and vision. Orpha.net

2. Strabismus surgery (if misalignment).
   Why. Improves ocular alignment for binocular vision development and cosmesis. Orpha.net

3. Cleft palate repair (if present).
   Why. Improves feeding, ear health, and speech resonance; coordinated with speech and dental teams. NCBI

4. Orthopedic procedures (e.g., tendon releases; patella/hip surgery).
   Why. Correct contractures and improve sitting/standing/walking; reduce pain. NCBI

5. Orchiopexy (undescended testes in males).
   Why. Protect fertility and lower torsion/cancer risks; usually within the first 1–2 years of life. MedlinePlus

---

Preventions

1. Stick to vaccine schedules to prevent severe infections. NCBI

2. Protect the eyes (lubricants, shielding in wind, sunglasses) to avoid corneal drying before/after eyelid surgery. Orpha.net

3. Oral hygiene with fluoride and regular dental visits—teeth anomalies raise decay risk. NCBI

4. Manage reflux/constipation early to prevent aspiration and feeding refusal. FDA Access Data+1

5. Home safety and seizure plans (rescue meds accessible). FDA Access Data

6. Hearing checks after ear infections to protect language learning. National Organization for Rare Disorders

7. Thyroid/growth monitoring to prevent developmental harm from untreated endocrine issues. FDA Access Data

8. Nightly routines and airway evaluation for snoring/apnea. NCBI

9. Orthoses and stretching to keep joints flexible and avoid deformity. NCBI

10. Genetic counseling for family planning and recurrence discussion. NCBI

---

When to see doctors (warning signs)

• Poor feeding, frequent choking, or weight loss (risk of aspiration and malnutrition). NCBI

• New or prolonged seizures, or color change with events (need medication review/rescue plan). FDA Access Data

• Eye redness, pain, or light sensitivity (exposure keratopathy). Orpha.net

• Worsening snoring, pauses in breathing, daytime sleepiness (possible sleep-disordered breathing). NCBI

• Constipation with vomiting or blood (impaction/other GI issues). FDA Access Data

• Regression of skills or sudden behavior change (medical or environmental trigger). NCBI

---

What to eat and what to avoid

Eat more of:

1. High-protein meals/snacks (supports growth and rehab). NCBI

2. Fiber-rich foods (whole grains, fruits, vegetables, legumes) to ease constipation. FDA Access Data

3. Healthy fats (olive oil, nut/seed butters if safe) and omega-3s (fatty fish) for energy and cognition. National Organization for Rare Disorders

4. Calcium + vitamin D sources (dairy/fortified foods) for bones. NCBI

5. Adequate fluids to prevent constipation and support mucus clearance. FDA Access Data

Limit/avoid:

1. Foods that worsen reflux near bedtime (spicy, very fatty, mint, caffeine). FDA Access Data
2. Hard/crumbly textures if oral-motor skills are weak (use therapist-guided textures). NCBI
3. Excess added sugars (dental decay risk; energy spikes). NCBI
4. Unverified supplements/“stem-cell” products marketed online. NCBI
5. Allergens confirmed by history/testing; keep an action plan. NCBI

---

FAQs

1. Is there a cure for SBBYS?
   No. Care targets symptoms (eyes, learning, movement, feeding, seizures, hormones, etc.). Genetics clinics coordinate long-term plans. NCBI

2. How is SBBYS diagnosed?
   By clinical features plus molecular testing of KAT6B. Testing also helps with family planning. NCBI

3. How is it different from genitopatellar syndrome (GPS)?
   Both are KAT6B disorders; many features overlap and form a spectrum. GIM Journal

4. Will my child learn to speak?
   Some do; others rely on AAC. Early speech therapy and AAC improve communication for everyone. NCBI

5. Are seizures common?
   They occur in a subset of patients; EEG and antiseizure therapy are used when needed. National Organization for Rare Disorders

6. Why are eyes such a focus?
   Blepharophimosis/ptosis can limit vision and dry the cornea. Eye protection and surgery planning are central. Orpha.net

7. What about kneecaps and walking?
   Patella hypoplasia/agenesis and joint contractures can affect mobility; PT, bracing, and selective surgery help. NCBI

8. Are thyroid problems part of SBBYS?
   Yes, congenital hypothyroidism can occur; levothyroxine restores normal thyroid levels. National Organization for Rare Disorders+1

9. Is behavior/autism support relevant?
   Yes—autism-like traits are reported; behavioral therapy and structured routines help. PMC

10. What specialists will we need?
    Genetics, pediatrics, ophthalmology, audiology, PT/OT/SLT, dentistry, cardiology, endocrinology, neurology, orthopedics, GI/nutrition. NCBI

11. Can growth hormone help every child?
    No—only when true GH deficiency or other label-approved indications exist. Endocrinology screens first. FDA Access Data+1

12. Are there experimental “stem-cell cures”?
    No approved stem-cell therapy exists for SBBYS; avoid unregulated clinics. NCBI

13. Will school services make a difference?
    Yes—IEP supports plus therapy embedded in class improve outcomes. MedlinePlus

14. What about long-term outlook?
    Highly variable; with coordinated care, many children gain functional communication, mobility, and social participation. NCBI

15. Where can we read reliable summaries?
    GeneReviews (KAT6B disorders), Orphanet disease pages, MedlinePlus Genetics, NORD, and recent peer-reviewed case series. National Organization for Rare Disorders+3NCBI+3Orpha.net+3

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: October 28, 2025.